Clinical Trial Update: A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) [Phase 3]

View source ↗

Summary

This entry describes an ongoing Phase 3 study evaluating the long-term safety and efficacy of Upadacitinib in Ulcerative Colitis. The trial is currently ACTIVE_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Upadacitinib (Rinvoq) (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Ulcerative Colitis (UC) | Phase 3 | Status: ACTIVE_NOT_RECRUITING